TP53 and cancer: This leads to enhanced expression of pro-apoptotic genes Puma, Noxa, and Bax in p53 mutant cells in addition to activation of cell-cycle genes and PARP cleavage independent of p53 mutation status, as observed in multiple studies that involved various types of cancer such as breast, thyroid, myeloma (30).